FDA’s New Leadership Aims to Overhaul Rare Disease Approvals - Bloomberg.com

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNWDFVdlVTZm9Mb3lqQV…; target="_blank">FDA’s New Leadership Aims to Overhaul Rare Disease Approvals</a>&nbsp;&nbsp;<font color="#6f6f6f">Bloomberg.com</font>